Palette Life Sciences Enters Into Definitive Agreement with Teleflex Incorporated - July 26, 2023read more
Palette Life Sciences Welcomes New Barrigel® Center of Excellence Program Designations - May 30, 2023read more
Palette Life Sciences Announces Launch of Barrigel® Center of Excellence Program and First Designations - May 2, 2023read more
Palette Life Sciences Announces Transaction With Global Healthcare Investor OrbiMed - March 21, 2023read more
Palette Life Sciences Announces Publication of Barrigel® Pivotal Safety and Efficacy Clinical Trial Data in JAMA Oncology- February 9, 2023read more
Palette Life Sciences Announces FDA 510(k) Clearance for Barrigel® Rectal Spacer, Proven Safe and Effective at Minimizing the Harmful Long-Term Side Effects of Prostate Radiation Therapy - June 9, 2022read more
Palette Life Sciences Receives Favorable Post Approval Study Results for Solesta® - March 29, 2022read more
Palette Life Sciences Enters Into an Agreement with Lantheus to Support the Promotion of PYLARIFY® (Piflufolastat F 18) - February 24, 2022read more
Palette Life Sciences Announces the Establishment of a Wholly Owned Subsidiary in Japan - February 15, 2022read more
Palette Life Sciences Celebrates Twenty Years of Deflux Treatment for Vesicoureteral Reflux (VUR) in the United States - November 9, 2021read more
